Skip to content Skip to sidebar Skip to footer

Newsletter

Small Caps Stocks

Activist investors: Here’s what you need to know about them and 4 famous Australian activists to watch out for

Hear the term 'Activist investors' and you might think of GetUp, the progressive activist group that forced Woolworths to hold an EGM in 2014 in an attempt to limit the maximum bets on poker machines to $1. Or perhaps even of ESG-focused fundies like Australian Ethical (ASX:AEF). The reality is a lot more complicated and…

ByNick SundichOctober 8, 2025

Acusensus (ASX: ACE) Surges 18% on Major USD 22 Million U.S. Contract Win

The AI-Driven Road Safety Company Winning Government Contracts Worldwide Acusensus (ASX: ACE) grabbed investors’ attention today after its share price surged 18 percent on news of a major contract win in the United States. The company secured a deal worth an estimated USD 22 million to deliver automated work zone speed control systems across Connecticut, marking…

ByCharlie YouldenOctober 7, 2025

Predictive Discovery (ASX:PDI) and Robex (ASK:RXR) are merging to become a major gold miner; but is West Africa too risky?

On Monday October 6 2025, whilst NSW and Queensland were on holiday, Predictive Discovery (ASX:PDI) and Robex (ASK:RXR) investors were informed of the news that their companies would be merging. Both companies were already well-positioned companies with individual gold mines that were amongst the lowest cost and most advanced. But this merger puts both companies in…

ByNick SundichOctober 7, 2025

Pepper Money (ASX:PPM): Flexibility is better…if you’re a borrower but what if you’re an investor?

Pepper Money's (ASX:PPM) promise to borrowers has been flexibility. You may not be 'good enough' to match the Big Banks' standards, but Pepper might be able to help. It had a >20 year history prior to its mid-2021 listing where it raised $500m at $2.89 per share, implying an A$1.3bn market capitalisation. And it has…

ByNick SundichOctober 6, 2025

Intelligent Monitoring Group (ASX:IMB): This >$200m All Ords company is Australasia’s largest independent security monitoring provider!

After a terrific FY24, FY25 was more difficult for Intelligent Monitoring Group (ASX:IMB) but it may have turned a corner. In FY24, this company (which we will call IMG to avoid confusion with the Illawarra-based mutual bank IMB) made >$40m EBITDA, went from being the 3rd largest company in its industry to the largest and set…

ByNick SundichOctober 2, 2025

DroneShield Surges 40% After Hitting 4,000 Units Sold and Securing AUD 7.9m in New Orders

Droneshield (ASX: DRO) has been one of the standout movers on the ASX in recent months, with the stock surging another 40 percent this week. For investors watching the defence technology space, this momentum reflects investor optimism on the back of the latest driver being a series of Department of Defence contracts that helped the…

ByCharlie YouldenOctober 1, 2025

Proteomics has launched 2 Promarker tests in a matter on months and is about to launch a 3rd

Proteomics' suite of Promarker tests are all being launched in 2025. The range includes: PromarkerD for DKD which has been launched in Australia and the USA; PromarkerEso for Esophageal cancer which is now commercially available in Australia, and PromarkerEndo for Endometriosis which will be commercialised shortly. Launching 3 tests in a a year is…

ByNick SundichSeptember 26, 2025

Maas Group (ASX:MGH): Why investors should keep a keen eye on it in FY26!

It is a tough time to be a construction company, but Maas Group (ASX:MGH) hasn't fared that bad all things considered. This company, which is roughly double its IPO price, recorded another good FY25 result, and investors took note of it. But the company is still very reasonably priced. What are the Best stocks to invest…

ByNick SundichSeptember 26, 2025

Amplia Therapeutics (ASX:ATX): Battling pancreatic cancer with an FAK inhibitor

Amplia Therapeutics (ASX:ATX) is another ASX oncology biotech company, attempting to battle cancer. At first glance, it may not a unique company but when you dig deeper...it is. It is using an 'FAK inhibitor' to fight pancreatic cancer (and potentially other indications down the track). What are the Best ASX Stocks to invest in right now?…

ByNick SundichSeptember 23, 2025

Yandal Resources Soars 60% on High-Grade Gold Discovery at Arrakis

Yandal Resources Unveils 54m Gold Hit at Arrakis, Shares Surge 60% Yandal Resources (ASX: YRL) has grabbed market attention with a share price jump of more than 60 percent after confirming a new gold discovery at its Arrakis Prospect in Western Australia. Investors were quick to react because the company drilled into fresh rock and…

ByCharlie YouldenSeptember 22, 2025

the Kick-ass Multipurpose WordPress Theme

Small Caps Stocks

Activist investors: Here’s what you need to know about them and 4 famous Australian activists to watch out for

Acusensus (ASX: ACE) Surges 18% on Major USD 22 Million U.S. Contract Win

Predictive Discovery (ASX:PDI) and Robex (ASK:RXR) are merging to become a major gold miner; but is West Africa too risky?

Pepper Money (ASX:PPM): Flexibility is better…if you’re a borrower but what if you’re an investor?

Intelligent Monitoring Group (ASX:IMB): This >$200m All Ords company is Australasia’s largest independent security monitoring provider!

DroneShield Surges 40% After Hitting 4,000 Units Sold and Securing AUD 7.9m in New Orders

Proteomics has launched 2 Promarker tests in a matter on months and is about to launch a 3rd

Maas Group (ASX:MGH): Why investors should keep a keen eye on it in FY26!

Amplia Therapeutics (ASX:ATX): Battling pancreatic cancer with an FAK inhibitor

Yandal Resources Soars 60% on High-Grade Gold Discovery at Arrakis

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Small Caps Stocks

Stocks in Spotlight

Add Your Heading Text Here